NCT01248338View on ClinicalTrials.gov

Effects of Nebivolol Versus Metoprolol Succinate on Endothelial Function

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2009

Conditions
Hypertension
Interventions
DRUG

metoprolol succinate

once daily 50 or 100 mg for one year

DRUG

Nebivolol

once daily 5 mg capsule for one year

Trial Locations (1)

51014

Cardiology Clinic of Tartu University Clinics, Tartu

All Listed Sponsors
lead

Berlin-Chemie AG Menarini Group

INDUSTRY

NCT01248338 - Effects of Nebivolol Versus Metoprolol Succinate on Endothelial Function | Biotech Hunter | Biotech Hunter